Tenofovir Disoproxil Fumarate CAS: 202138-50-9
| Product Parameters | |
|---|---|
| Catalog No. | BK6M1G |
| CAS.RN | 202138-50-9 |
| Molecular Formula | C23H34N5O14P |
| Molecular Weight | 635.51 g/mol |
| Purity | NLT 98% |
| Synonyms | Sugammadex;Tenofovir DF |
Product Overview
Tenofovir Disoproxil Fumarate is an important pharmaceutical intermediate widely used in the synthesis of nucleoside antiviral drugs, particularly in the treatment of HIV and hepatitis B. As a key precursor, this product is suitable for various stages of drug development, from small-scale preparation to pilot-scale amplification and commercial production. It exhibits excellent chemical stability and processability, meeting the pharmaceutical companies' demand for high-purity, high-quality raw materials and helping customers efficiently advance drug development and industrialization.
Applications
- Synthesis of nucleoside antiviral drugs
- Intermediates for HIV/AIDS treatment drugs
- Progenitors of hepatitis B virus inhibitors
- Optimization of drug manufacturing processes
- Customized pharmaceutical synthesis projects
Quality & Supply Capability
English Name: Tenofovir Disoproxil Fumarate Properties: White to off-white crystalline powder, readily soluble in water, with good chemical stability. The core functional group is a phosphate ester group, suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control requirements, packaging specifications, and delivery cycles according to customer needs, with a complete quality documentation system to ensure product compliance with GMP and industry standards. Simultaneously, we provide comprehensive technical support from laboratory R&D to industrial production, assisting customers in process development, route optimization, and project transformation, improving R&D efficiency and production reliability.
Why Choose Bioncan
Focused on pharmaceutical nucleosides and pharmaceutical intermediates, possessing a rich product line and accumulated technology. Full-scale supply capability, covering all stages from laboratory to commercial production. Provides complete quality control documentation, including COA, HPLC, NMR, etc., ensuring controllable product quality. Supports customized needs, and can adjust formulations and optimize processes according to specific customer requirements. Provides scale-up technical support to help customers achieve a smooth transition from R&D to mass production.
Intermediates of Tenofovir
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA416P | Tenofovir API | 147127-20-6 |
| BK6M1G | Tenofovir Disoproxil Fumarate | 202138-50-9 |
| BK7C14 | Chloromethyl isopropyl carbonate | 31618-90-3 |
| BK49JU | Magnesium dipropan-2-olate | 15571-48-9 |
| BK8M4C | Tenofovir Alafenamide fumarate | 1392275-56-7 |
| BK36DG | Tenofovir disoproxil | 201341-05-1 |
| BK29M0 | Chloromethyl isopropyl carbonate | 35180-01-9 |
| BK1Y2W | (R)-(+)-Propylene carbonate | 16606-55-6 |
| BK01T3 | (R)-9-(2-Hydroxypropyl)adenine | 14047-28-0 |
| BK4E41 | (R)-9-(2-phosphonylmethoxypropyl)adenine | 206184-49-8 |
| BK072K | Diethyl (hydroxymethyl)phosphonate | 3084-40-0 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 202138-50-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
